Changing views on the place of drugs in the treatment of chronic heart failure
Sidorenko, B.A.; Preobrazhenskiĭ, D.V.
Kardiologiia 45(3): 90-91
2005
ISSN/ISBN: 0022-9040 PMID: 15821722 Document Number: 585216
Document emailed within 1 workday
Related Documents
Sidorenko, B.A.; Preobrazhenskiĭ, D.V.; Sharoshina, I.A.; Makhmutodzhaev, S.A.; Batyraliev, T.A.; Pershukov, I.V. 2005: The place of cardiac glycosides in the treatment of chronic heart failure Kardiologiia 45(4): 85-91Halawa, B. 1996: Contemporary views of pharmacologic treatment for congestive heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 1(5): 299-302
Follath, F. 1992: New positive inotropic drugs in acute and chronic heart failure Schweizerische Rundschau für Medizin Praxis 81(21): 704-707
Goenen, M.J. 1986: New inotropic-vasodilating drugs in acute and chronic heart failure Annales de Medecine Interne 137(3): 229-234
Feenstra, J.; Heerdink, E.R.; Grobbee, D.E.; Stricker, B.H.Ch. 2002: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Archives of Internal Medicine 162(3): 265-270
Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Pierach, C.A.; Jarosch, P.F. 1974: Treatment of heart failure with vasodilator drugs Münchener Medizinische Wochenschrift 116(39): 1689-1690
Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S. 2011: The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure Likars'ka Sprava 2011(7-8): 51-58
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Martínez Martínez, J.A. 1999: Betablockers and the treatment of chronic heart failure Medicina 59(6): 793-797
Brito, D. 2001: Guidelines for the diagnosis and treatment of chronic heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20(10): 1049-1051
Okuda, S.; Yano, M. 2011: Guidelines for treatment of chronic heart failure (JCS 2010) Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl. 9: 595-604
Riecanský, I.; Chudiková, J.; Plachá, L. 1972: Glucagon in the treatment of chronic congestive heart failure Bratislavske Lekarske Listy 58(4): 468-476
Sidorenko, B.A.; Preobrazhenskiĭ, D.V.; Batyraliev, T.A.; Pershukov, I.V.; Makhmutkhodzhaev, S.A. 2006: Contemporary approaches to the treatment of chronic heart failure in adults (after materials of recommendations of American College of Cardiology and American Heart Association, 2005) Kardiologiia 46(4): 95-102
Cleland, J.G. 1994: Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? British Journal of Hospital Medicine 52(5): 193; 195-196
Klabník, A.; Murín, J.; Kycina, P. 2010: Gender differences in non-pharmacological treatment of chronic heart failure Vnitrni Lekarstvi 56(5): 427-433
Lechat, P. 1989: Treatment of chronic heart failure with positive inotropic agents Therapie 44(6): 437-445
Bundkirchen, A.; Brixius, K.; Schwinger, R.H.G. 2004: Beta-adrenoceptor antagonists in the treatment of chronic heart failure Die Pharmazie 59(2): 83-92
Zannad, F. 1992: Management of the treatment with converting enzyme inhibitors in chronic heart failure La Revue du Praticien 42(20): 2563-2567